Banner - Collaborative Care Symposium
News
All NewsPractice Management
Media
All VideosExpert InterviewsPodcastsMedical World NewsViewpointsInsightsCase Based Roundtable SeriesCase StudiesCase of the QuarterPractice OwnershipRapid ReadoutVideo SeriesWhat’s Your WhEYE?
Conferences
Conference CoverageConference ListingConference Recaps
Blog
More
Publications
Digital EditionSupplements And Featured PublicationsiTech
Partners
Resources
Job BoardSponsored
CE

Subscribe

  • News
  • Media
  • Conferences
  • Blog
  • Publications
  • Partners
  • Resources
  • Subscribe
  • CE
  • AMD
  • Allergy
  • Blepharitis
  • COVID-19
  • Cataract
  • Comanagement
  • Comprehensive Eye Exams
  • Conjunctivitis
  • Contact Lenses
  • Cornea
  • DME
  • Diabetic Eye Disease
  • Dry Eye
  • Geographic Atrophy
  • Glasses
  • Glaucoma
  • LASIK
  • Lens Technology
  • Lid and Lash
  • Myopia
  • Nutrition
  • OCT
  • Ocular Surface Disease
  • Optic Relief
  • Patient Care
  • Pediatrics
  • Presbyopia
  • Ptosis
  • Refractive Surgery
  • Retina
  • Technology
  • Therapeutic Cataract & Refractive
Spotlight -
Geographic Atrophy|
Myopia
Advertisement

Alex Hacopian, MD

Advertisement

Articles by Alex Hacopian, MD

At ASCRS 2025, Alex Hacopian, MD, shares information from his presentation on next-gen presbyopia-correcting intraocular lenses.

ASCRS 2025: Enhancing patient outcomes with presbyopia-correcting IOLs

ByAlex Hacopian, MD,Emily Kaiser Maharjan, Assistant Managing Editor,Hattie Hayes,Sheryl Stevenson, Eye Care Group Editorial Director
April 30th 2025

At ASCRS 2025, Alex Hacopian, MD, shares information from his presentation on next-gen presbyopia-correcting intraocular lenses.

Advertisement

Latest Updated Articles



    Advertisement
    Advertisement

    Trending on Optometry Times - Clinical News & Expert Optometrist Insights

    1

    “Family business?” Navigating the business of treating family

    2

    Ortho-k: More than meets the eye to control myopia progression

    3

    ONL Therapeutics reports positive phase 1b data for xelafaslatide in GA

    4

    Improved grading scales for oncology drugs causing ocular adverse events

    5

    What advancements optometrists are hoping for in 2026: Part 1

    • Advertise
    • About Us
    • Editorial
    • Contact Us
    • Job Board
    • Terms & Conditions
    • Privacy
    • Do not sell my Information
    Contact Info

    259 Prospect Plains Rd, Bldg H
    Cranbury, NJ 08512

    609-716-7777

    • Ophthalmology Times
    • Modern Retina
    • Optometry Times
    • Ophthalmology Times Europe
    Collaborative Care Symposium
    Brand Logo

    © 2025 MJH Life Sciences®

    All rights reserved.

    Home
    About Us
    News
    Contact Us